2 results
Approved WMOCompleted
The objective of the study is to confirm that PCNSL is positive on 89Zr-rituximab PET imaging.
Approved WMOCompleted
This study aims to test the hypothesis that zandelisib in combination with rituximab has better clinical activity and risk/benefit profile compared to standard 2nd line immunochemotherapy (R-CHOP/R-B) in subjects with relapsed FL or MZL. Primary…